statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	409
SG - Singapore	293
RU - Federazione Russa	217
CN - Cina	102
HK - Hong Kong	52
BR - Brasile	47
VN - Vietnam	46
IT - Italia	37
IE - Irlanda	28
NL - Olanda	27
DE - Germania	26
FI - Finlandia	26
SE - Svezia	19
GB - Regno Unito	14
AR - Argentina	11
CA - Canada	10
FR - Francia	7
PL - Polonia	4
TR - Turchia	4
AU - Australia	3
BD - Bangladesh	3
CI - Costa d'Avorio	3
CO - Colombia	3
CZ - Repubblica Ceca	3
EC - Ecuador	3
DZ - Algeria	2
EG - Egitto	2
IN - India	2
MA - Marocco	2
MX - Messico	2
NP - Nepal	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AQ - Antartide	1
BB - Barbados	1
BH - Bahrain	1
BO - Bolivia	1
BW - Botswana	1
CG - Congo	1
CL - Cile	1
CR - Costa Rica	1
CU - Cuba	1
EE - Estonia	1
ES - Italia	1
GN - Guinea	1
GY - Guiana	1
HU - Ungheria	1
ID - Indonesia	1
IL - Israele	1
IQ - Iraq	1
JP - Giappone	1
KZ - Kazakistan	1
LC - Santa Lucia	1
LT - Lituania	1
MM - Myanmar	1
PT - Portogallo	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SO - Somalia	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	1.442

Nome	#
Synthesis and NMR characterization of a novel crown ether ring-fused uridine analogue	120
Design, Synthesis and Characterisation of novel amphiphilic guanosine derivatives	106
Amphiphilic nucleoside complexes of ruthenium (III): a novel strategy in anticancer research	103
On the compatibility of azides in phosphoramidite-based couplings: synthesis of a novel, convertible azido-functionalized CyPLOS analogue.	99
Synthesis and characterization of new amphiphilic complexes of ruthenium(III) as potential antitumoral agents	95
Ruthenium-based complex nanocarriers forcancer therapy	95
Fluorescently-labelled nucleolipid Ru(III) complexes: investigating the in vivo mechanism of action of anticancer ruthenium derivatives	95
Guanosine-based amphiphiles: synthesis, biophysical characterization and biological activity	93
CyPLOS, novel carbohydrate-based synthetic ion transporters	92
Novel Nucleoside-based Complexes of Ruthenium (III) as Potential Antitumoral Agents	84
A Cholesterol-based Nucleolipid-Ruthenium complex stabilized bylipid aggregates for antineoplastic therapy	82
Design, Synthesis and Characterization of novel amphiphilicGuanosine-based Nucleolipids	81
Design, Synthesis and Characterization of novel amphiphilic Guanosine-based Nucleolipids	80
Guanosine-based Nucleolipids: Design, Synthesis and Gelling Properties	79
On the compatibility of azides in phosphoramidite-based couplings: a 31P-NMR study	74
Design and Synthesis of novel amphiphilic Guanosine-based Nucleolipids	72
Totale	1.450

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	2	2	2	5	0
2021/2022	83	2	0	0	1	0	3	0	6	26	2	4	39
2022/2023	163	16	6	6	11	24	14	0	17	35	26	8	0
2023/2024	72	3	21	13	4	1	1	0	7	0	1	15	6
2024/2025	441	23	25	2	3	13	25	54	35	24	25	177	35
2025/2026	588	80	56	106	90	191	29	36	0	0	0	0	0
Totale													1.450